Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
fkansteiner
Tue, 12/07/2021 – 09:37